Please login to the form below

Not currently logged in
Email:
Password:

Epidyolex

This page shows the latest Epidyolex news and features for those working in and with pharma, biotech and healthcare.

FDA clears SK Life Science’s anti-epileptic drug Xcopri

FDA clears SK Life Science’s anti-epileptic drug Xcopri

This includes GW Pharma’s  Epidyolex, which is the first medicine based on a highly-purified, plant derived CBD, which lacks the high associated with cannabis or marijuana.

Latest news

  • NICE backs first cannabis-based drugs, both from GW Pharma NICE backs first cannabis-based drugs, both from GW Pharma

    2014. NICE turned down Epidyolex in  draft guidance, but has changed its stance after a price reduction from the manufacturer. ... Oral liquid  Epidyolex was approved in Europe for severe epilepsy in September, becoming the first drug to be approved

  • GW Pharma’s Epidyolex gets EU approval for severe epilepsy GW Pharma’s Epidyolex gets EU approval for severe epilepsy

    Epidyolex could provide a licensed option that doctors will feel more comfortable prescribing, provided GW Pharma can secure NICE’s backing for NHS prescribing of the drug. ... The company – which has said it intends to launch Epidyolex in France,

  • Early ‘no’ for GW Pharma’s epilepsy drug, but NICE vows to collaborate Early ‘no’ for GW Pharma’s epilepsy drug, but NICE vows to collaborate

    Judgement arrives ahead of European approval. GW Pharma’s Epidyolex for two types of severe treatment-resistant epilepsy has been given a preliminary rejection by England’s NICE – but the cost ... NICE’s draft guidance issued today is remarkable

  • CHMP backs Bayer’s tumour-agnostic drug Vitrakvi CHMP backs Bayer’s tumour-agnostic drug Vitrakvi

    GW Pharma’s Epidyolex also on the recommended list. Bayer’s Vitrakvi has become the first drug in Europe recommended to treat cancer based on a molecular signature, rather than where ... The CHMP has also granted a positive opinion for GW Pharma’s

More from news
Approximately 3 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Syneos Health®

Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and...

Latest intelligence

What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...